These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 15771451

  • 1. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
    Waern JB, Dillon CT, Harding MM.
    J Med Chem; 2005 Mar 24; 48(6):2093-9. PubMed ID: 15771451
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genotoxicity and transmission electron microscopy studies of molybdocene dichloride.
    Campbell KS, Foster AJ, Dillon CT, Harding MM.
    J Inorg Biochem; 2006 Jul 24; 100(7):1194-8. PubMed ID: 16527357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inclusion complexes of the antitumour metallocenes Cp(2)MCl(2) (M = Mo, Ti) with cucurbit[n]urils.
    Buck DP, Abeysinghe PM, Cullinane C, Day AI, Collins JG, Harding MM.
    Dalton Trans; 2008 May 07; (17):2328-34. PubMed ID: 18414758
    [Abstract] [Full Text] [Related]

  • 6. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
    Abeysinghe PM, Harding MM.
    Dalton Trans; 2007 Aug 28; (32):3474-82. PubMed ID: 17680034
    [Abstract] [Full Text] [Related]

  • 7. Apoptosis-inducing vanadocene compounds against human testicular cancer.
    Ghosh P, D'Cruz OJ, Narla RK, Uckun FM.
    Clin Cancer Res; 2000 Apr 28; 6(4):1536-45. PubMed ID: 10778987
    [Abstract] [Full Text] [Related]

  • 8. A (1)H NMR study of the interaction of antitumor metallocenes with glutathione.
    Mokdsi G, Harding MM.
    J Inorg Biochem; 2001 Sep 28; 86(2-3):611-6. PubMed ID: 11566334
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
    Peri D, Meker S, Shavit M, Tshuva EY.
    Chemistry; 2009 Sep 28; 15(10):2403-15. PubMed ID: 19156656
    [Abstract] [Full Text] [Related]

  • 10. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF, Parsons S, Sadler PJ.
    J Am Chem Soc; 2007 Mar 21; 129(11):3348-57. PubMed ID: 17319668
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic activity of new lanthanum (III) complexes of bis-coumarins.
    Kostova I, Momekov G, Zaharieva M, Karaivanova M.
    Eur J Med Chem; 2005 Jun 21; 40(6):542-51. PubMed ID: 15922838
    [Abstract] [Full Text] [Related]

  • 12. Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.
    Waern JB, Harris HH, Lai B, Cai Z, Harding MM, Dillon CT.
    J Biol Inorg Chem; 2005 Aug 21; 10(5):443-52. PubMed ID: 15906108
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C.
    J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861
    [Abstract] [Full Text] [Related]

  • 14. Ruthenium(III) maltolato-nitroimidazole complexes: synthesis and biological activity.
    Kennedy DC, Wu A, Patrick BO, James BR.
    J Inorg Biochem; 2006 Dec 14; 100(12):1974-82. PubMed ID: 16938347
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
    Thomadaki H, Karaliota A, Litos C, Scorilas A.
    J Med Chem; 2007 Mar 22; 50(6):1316-21. PubMed ID: 17328533
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
    Trávnícek Z, Szucová L, Popa I.
    J Inorg Biochem; 2007 Mar 22; 101(3):477-92. PubMed ID: 17208304
    [Abstract] [Full Text] [Related]

  • 17. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.
    Ang WH, Daldini E, Scolaro C, Scopelliti R, Juillerat-Jeannerat L, Dyson PJ.
    Inorg Chem; 2006 Oct 30; 45(22):9006-13. PubMed ID: 17054361
    [Abstract] [Full Text] [Related]

  • 18. Palladium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones: spectral characterization, structural studies and cytotoxic activity.
    Rebolledo AP, Vieites M, Gambino D, Piro OE, Castellano EE, Zani CL, Souza-Fagundes EM, Teixeira LR, Batista AA, Beraldo H.
    J Inorg Biochem; 2005 Mar 30; 99(3):698-706. PubMed ID: 15708790
    [Abstract] [Full Text] [Related]

  • 19. Pyrophosphate-bridged complexes with picomolar toxicity.
    Ikotun OF, Higbee EM, Ouellette W, Doyle RP.
    J Inorg Biochem; 2009 Sep 30; 103(9):1254-64. PubMed ID: 19666193
    [Abstract] [Full Text] [Related]

  • 20. 3,5-Dimethyl-1-thiocarbamoylpyrazole and its Pd(II) complexes: synthesis, spectral studies and antitumor activity.
    Rocha FV, Barra CV, Netto AV, Mauro AE, Carlos IZ, Frem RC, Ananias SR, Quilles MB, Stevanato A, da Rocha MC.
    Eur J Med Chem; 2010 May 30; 45(5):1698-702. PubMed ID: 20116142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.